Cholesterol homeostasis in pathogenesis of DR

DR 发病机制中的胆固醇稳态

基本信息

  • 批准号:
    10693905
  • 负责人:
  • 金额:
    $ 38.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Disruptions in cholesterol homeostasis and metabolism can lead to high cholesterol concentrations in diseased tissue and the formation of cholesterol crystals (CC). CC are often overlooked in traditional histo/immunohistochemistry as the ethanol, used for tissue processing, can dissolve them. This masks CC presence and potential involvement in pathogenic mechanisms. Using Scanning Electron Microscopy (SEM) of tissues prepared without an ethanol dehydration step, we identified the presence of CC: i) in “lipid pools” between retinal pigment epithelium (RPE) and photoreceptors (PR); ii) circulating freely in diabetic murine blood; and iii) within circulating monocytes of diabetic human subjects. Since CC are very stable physiologically and are not easily amenable to dissolving in vivo, they become a source of chronic inflammation. CC are recognized by the innate immune system as foreign bodies because of their shape, firmness, and inability to be dissolved. Moreover, CC also induce inflammation via the NLRP3 inflammasome activation. These novel preliminary and published studies have led us to propose the following hypothesis (see schematic in Fig.1): Diabetes- induced disruption of i) systemic cholesterol homeostasis, ii) blood retinal barrier function; and iii) SIRT1, LXR and CYP46A1 expression alters retinal cholesterol homeostasis leading to CC formation within key locations: RPE, PR, monocytes/macrophages, and in the circulation affecting the endothelium. This CC formation results in intra- and extracellular complement activation and priming of the NLRP3 inflammasome for its activation and release of highly damaging pro-inflammatory cytokines, promoting development of DR. To test this hypothesis, we propose the following Specific Aims: Aim1: To determine the temporal changes in retinal cholesterol accumulation that lead to CC formation. Aim 2: To test the hypothesis that diabetes- induced cholesterol accumulation and CC formation in the retina and in monocytes/macrophages induces activation of intracellular and extracellular complement to trigger the NLRP3 inflammasome and IL-1β production. Aim 3: To test the hypothesis that LXR activation and direct sequestration of cholesterol by alpha-cyclodextrin can inhibit CC-induced complosome and NLRP3 inflammasome formation in the diabetic retina and in monocytes/macrophages cells, thus preventing chronic inflammation and development of DR. Impact: The successful completion of this project will result in identifying an entirely novel pathway in which CC-induced complosome and NLRP3 inflammasome formation that can be pharmacologically targeted to prevent DR.
胆固醇体内平衡和代谢的破坏可导致高胆固醇

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The role of dyslipidemia in diabetic retinopathy.
  • DOI:
    10.1016/j.visres.2017.04.010
  • 发表时间:
    2017-10
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    Hammer SS;Busik JV
  • 通讯作者:
    Busik JV
Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway.
  • DOI:
    10.2337/db17-1587
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Huang C;Fisher KP;Hammer SS;Navitskaya S;Blanchard GJ;Busik JV
  • 通讯作者:
    Busik JV
Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.
COVID-19受试者中的血浆微生物组:肠道屏障缺陷和营养不良的指标。
Ceramide-mediation of diffusion in supported lipid bilayers.
  • DOI:
    10.1016/j.chemphyslip.2021.105090
  • 发表时间:
    2021-08
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Hossain M;Blanchard GJ
  • 通讯作者:
    Blanchard GJ
Effects of ethanol and n-butanol on the fluidity of supported lipid bilayers.
  • DOI:
    10.1016/j.chemphyslip.2021.105091
  • 发表时间:
    2021-08
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Hossain M;Blanchard GJ
  • 通讯作者:
    Blanchard GJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julia V Busik其他文献

Julia V Busik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julia V Busik', 18)}}的其他基金

Anti-ceramide immunotherapy for diabetic retinopathy
抗神经酰胺免疫疗法治疗糖尿病视网膜病变
  • 批准号:
    10440369
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
Anti-ceramide immunotherapy for diabetic retinopathy
抗神经酰胺免疫疗法治疗糖尿病视网膜病变
  • 批准号:
    10200072
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
通过新型微流体 O2 传感和仿生电化学研究神经酰胺介导的糖尿病视网膜病变线粒体损伤
  • 批准号:
    9904655
  • 财政年份:
    2018
  • 资助金额:
    $ 38.88万
  • 项目类别:
Ceramide-mediated mitochondrial damage in diabetic retinopathy investigated by novel microfluidic O2 sensing and bio-mimetic electrochemistry
通过新型微流体 O2 传感和仿生电化学研究神经酰胺介导的糖尿病视网膜病变线粒体损伤
  • 批准号:
    10132325
  • 财政年份:
    2018
  • 资助金额:
    $ 38.88万
  • 项目类别:
Cholesterol homeostasis in pathogenesis of DR
DR 发病机制中的胆固醇稳态
  • 批准号:
    10226319
  • 财政年份:
    2015
  • 资助金额:
    $ 38.88万
  • 项目类别:
Cholesterol homeostasis in pathogenesis of DR
DR 发病机制中的胆固醇稳态
  • 批准号:
    10542239
  • 财政年份:
    2015
  • 资助金额:
    $ 38.88万
  • 项目类别:
Dyslipidemia and Diabetic Retinopathy
血脂异常和糖尿病视网膜病变
  • 批准号:
    10478284
  • 财政年份:
    2005
  • 资助金额:
    $ 38.88万
  • 项目类别:
Dyslipidemia and Diabetic Retinopathy
血脂异常和糖尿病视网膜病变
  • 批准号:
    10659205
  • 财政年份:
    2005
  • 资助金额:
    $ 38.88万
  • 项目类别:
Dyslipidemia and diabetic retinopathy
血脂异常和糖尿病视网膜病变
  • 批准号:
    6984993
  • 财政年份:
    2005
  • 资助金额:
    $ 38.88万
  • 项目类别:
Dyslipidemia and diabetic retinopathy
血脂异常和糖尿病视网膜病变
  • 批准号:
    7271200
  • 财政年份:
    2005
  • 资助金额:
    $ 38.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了